Open AccessMedicine
I. Perez, Sara Taveras Alam, Gabriel A. Hernandez, Rhea Sancassani
tlooto Summary
Cancer therapy-related cardiac dysfunction is one of the most feared and undesirable side effects of chemotherapy, occurring in approximately 10% of the patients.
Abstract
Cancer therapy-related cardiac dysfunction (CTRCD) is one of the most feared and undesirable side effects of chemotherapy, occurring in approximately 10% of the patients. It can be classified as direct (dose-dependent vs dose-independent) or indirect, either case being potentially permanent or reversible. Risk assessment, recognition, and prevention of CTRCD are crucial.
Citation format
PEREZ, I., et al. Cancer therapy-related cardiac dysfunction: An overview for the clinician. Clinical Medicine Insights-Cardiology, 2019, 13.